Zura Bio Limited (ZURA)
NASDAQ: ZURA · Real-Time Price · USD
6.23
+0.35 (5.95%)
At close: Sep 4, 2026, 4:00 PM EDT
6.24
+0.01 (0.16%)
After-hours: Sep 4, 2026, 7:53 PM EDT
Zura Bio Market Cap
Zura Bio has a market cap or net worth of $597.02 million as of September 4, 2026. Its market cap has increased by 352.33% in one year.
Market Cap
597.02M
Enterprise Value
391.88M
1-Year Change
352.33%
Ranking
Category
Stock Price
$6.23
ChartMarket Cap Chart
Since September 3, 2021, Zura Bio's market cap has increased from $167.33M to $597.02M, an increase of 256.80%. That is a compound annual growth rate of 28.93%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 4, 2026 | 597.02M | 75.22% |
| Dec 31, 2025 | 340.72M | 108.73% |
| Dec 31, 2024 | 163.23M | -19.82% |
| Dec 29, 2023 | 203.58M | 15.59% |
| Dec 30, 2022 | 176.12M | 3.44% |
| Dec 31, 2021 | 170.26M | 1.75% |
| Sep 3, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| REGENXBIO | 607.32M |
| Eikon Therapeutics | 593.65M |
| Cabaletta Bio | 590.02M |
| Tectonic Therapeutic | 584.92M |
| Scribe Therapeutics | 581.21M |
| ProKidney | 580.46M |
| ARS Pharmaceuticals | 563.87M |
| Artiva Biotherapeutics | 543.90M |